Risk Factors for Low Enrollment in Cancer Trials Spelled Out

Drug Industry Daily
A A
Roughly a fifth of cancer clinical trials fail to recruit enough participants, creating a “major barrier to progress” for developing new therapies, according to a paper published in the Journal of the National Cancer Institute.

To View This Article:

Login

Subscribe To Drug Industry Daily